Demo Sign up Log In

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)

R&D Expenses

£3.47B

Quarterly · Period ending: Jun 30, 2026 · GBP

GSK R&D Expenses

Latest reported£3.47B GBPperiod endingJun 30, 2026

Latest reported£3.47B GBPperiod endingJun 30, 2026

GSK Quarterly R&D Expenses · GBP (£0.00 → £3.47B)

Quarterly R&D Expenses

High-resolution chart · PNG

GSK r&d expenses history

Quarterly · GBP. Dates are reporting period ends; fiscal years can differ from calendar years.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) R&D Expenses — Quarterly (GBP)
Period ending	R&D Expenses (GBP)
Jun 30, 2001	656,000,000
Mar 31, 2001	595,000,000
Dec 31, 2000	729,000,000
Sep 30, 2000	639,000,000
Jun 30, 2000	617,000,000
Mar 31, 2000	541,000,000
Dec 31, 1999	0
Sep 30, 1999	0
Jun 30, 1999	297,980,000
Mar 31, 1999	0
Dec 31, 1998	0
Sep 30, 1998	0
Jun 30, 1998	275,880,400
Mar 31, 1998	0
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Dec 31, 1987	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0
Mar 31, 1986	0
Dec 31, 1985	0
Sep 30, 1985	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.